ONE WORLD PHARMA, INC. (PNTTE) financial statements (2021 and earlier)

Company profile

Business Address 3471 WEST OQUENDO ROAD, SUITE 301
LAS VEGAS, NV 89118
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
9/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments    36
Cash and cash equivalents    36
Prepaid expense 1   1
Total current assets: 1  36
Noncurrent Assets
TOTAL ASSETS: 1  36
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 010118 
Accounts payable 0    
Other undisclosed accounts payable and accrued liabilities  10118 
Due to related parties 0883114 
Total current liabilities: 0984123 
Noncurrent Liabilities
Liabilities, other than long-term debt     3
Due to related parties     3
Total noncurrent liabilities:     3
Total liabilities: 09841233
Stockholders' equity
Stockholders' equity attributable to parent 0(98)(41)(20)3
Common stock 15555
Additional paid in capital 15425252525
Accumulated deficit (155)(128)(71)(49)(27)
Total stockholders' equity: 0(98)(41)(20)3
TOTAL LIABILITIES AND EQUITY: 1  36

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
9/30/2015
Operating expenses (27)(57)(37) (27)
Other operating expense, net
(Other Nonrecurring (Income) Expense)
     (4)
Other undisclosed operating income     4
Operating loss: (27)(57)(37) (27)
Nonoperating income
(Investment Income, Nonoperating)
   15  
Net loss available to common stockholders, diluted: (27)(57)(22) (27)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
9/30/2015
Net loss: (27)(57)(22) (27)
Comprehensive loss, net of tax, attributable to parent: (27)(57)(22) (27)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: